Global Heart Valve Devices Market
Taille du marché en milliards USD
TCAC : %
Période de prévision |
2023 –2030 |
Taille du marché (année de référence) |
|
Taille du marché (année de prévision) |
Dollars américains 23,665.51 |
TCAC |
|
Principaux acteurs du marché |
Marché mondial des dispositifs de valve cardiaque, par type de produit (valves cardiaques mécaniques, valves cardiaques biologiques et valves transcathéter), traitement (chirurgie ouverte et chirurgie mini-invasive (MIS)), utilisateur final (hôpitaux et cliniques, centres de chirurgie ambulatoire , centres cardiaques, centres de recherche et autres), canal de distribution (appel d'offres direct, distributeurs tiers), tendances de l'industrie et prévisions jusqu'en 2030.
Analyse et perspectives du marché des dispositifs valvulaires cardiaques
Les dispositifs de valve cardiaque sont utilisés pour traiter les valves cardiaques bloquées, et l'implantation de ces dispositifs est l'une des procédures les plus courantes. Les dispositifs de valve cardiaque structurels disponibles sur le marché comprennent les valves mécaniques, biologiques et transcathéter. Le marché mondial des dispositifs de valve cardiaque devrait croître régulièrement au cours de la période de prévision en raison du nombre croissant d'interventions chirurgicales de valve cardiaque à travers le monde. La croissance du marché mondial des dispositifs de valve cardiaque devrait être tirée par les développements des dispositifs et procédures cardiaques structurels tels que les valves aortiques, les dispositifs d'occlusion auriculaire gauche et les valves tissulaires ou biologiques. Les valves tissulaires ont déjà révolutionné le marché des dispositifs de valve cardiaque. Les chirurgies de valve cardiaque de nouvelle génération offrent des profils de patients à faible accouchement, des chirurgies plus contrôlées, une meilleure fonction de valve, une régurgitation paravalvulaire réduite, une durabilité accrue et des coûts inférieurs. Les innovations de produits des principaux acteurs du marché ont stimulé la croissance du marché en leur permettant de s'adresser à une population de patients plus large et d'obtenir de meilleurs résultats cliniques.
Data Bridge Market Research analyse que le marché des dispositifs de valves cardiaques devrait atteindre la valeur de 23 665,51 millions USD d'ici 2030, à un TCAC de 13,4 % au cours de la période de prévision. Le type de produit représente le segment de type le plus important du marché en raison de la demande rapide de dispositifs de valves cardiaques à l'échelle mondiale. Ce rapport de marché couvre également en profondeur l'analyse des prix, l'analyse des brevets et les avancées technologiques.
Rapport métrique |
Détails |
Période de prévision |
2023 à 2030 |
Année de base |
2022 |
Années historiques |
2021 (personnalisable de 2020 à 2015) |
Unités quantitatives |
Chiffre d'affaires en millions USD, volumes en unités, prix en USD |
Segments couverts |
Par type de produit (valves cardiaques mécaniques, valves cardiaques biologiques et valves transcathéter), traitement (chirurgie ouverte et chirurgie mini-invasive (MIS)), utilisateur final (hôpitaux et cliniques, centres de chirurgie ambulatoire, centres cardiaques, centres de recherche et autres), canal de distribution (appel d'offres direct, distributeurs tiers). |
Pays couverts |
États-Unis, Canada, Mexique, Allemagne, France, Royaume-Uni, Italie, Russie, Espagne, Pays-Bas, Suisse, Norvège, Pologne, Suède, Belgique, Turquie, Danemark, Finlande et le reste de l'Europe, Chine, Japon, Inde, Australie, Nouvelle-Zélande, Corée du Sud, Singapour, Malaisie, Thaïlande, Indonésie, Philippines, Vietnam, Taïwan et le reste de l'Asie-Pacifique, Afrique du Sud, Arabie saoudite, Bahreïn, Émirats arabes unis, Koweït, Oman, Qatar, Israël, Égypte et le reste du Moyen-Orient et de l'Afrique, Brésil, Argentine et le reste de l'Amérique du Sud. |
Acteurs du marché couverts |
Abbott, Boston Scientific Corporation ou ses sociétés affiliées, Artivion, Inc., Edwards Lifesciences Corporation, Medtronic, NeoVasc, Micro Interventional Devices Incorporated, XELTIS, TTK, Meril Life Sciences Pvt. Ltd, Foldax, Inc., Venus Medtech (Hangzhou) Inc., Colibri Heart Valve, entre autres. |
Définition du marché mondial des dispositifs de valve cardiaque
Les valves cardiaques sont nécessaires pour fluidifier le mouvement du sang dans la bonne direction dans le corps. Les valves cardiaques sont responsables du flux sanguin constant et du maintien de la pression artérielle. Si elles ne fonctionnent pas correctement, la coupure du cœur provoque une sténose. Les maladies cardiaques comprennent généralement plusieurs maladies qui affectent considérablement le cœur. La régulation des valves cardiaques a augmenté rapidement au cours des dix dernières années, car le nombre de patients souffrant de maladies cardiovasculaires a augmenté. La croissance du marché des valves cardiaques est accélérée par des facteurs tels que les modes de vie instables, les maladies liées au mode de vie, l'augmentation de la population tabagique, le vieillissement de la population, l'amélioration de la qualité des soins de santé et le développement rapide du remboursement des soins de santé au cours de la période de prévision. En outre, le coût élevé des valves cardiaques et le risque d'infection des implants cardiaques peuvent être la raison qui est susceptible de ralentir la croissance du marché des valves cardiaques au cours de la période de prévision susmentionnée. La croissance des aspects commerciaux médicaux et le travail préparatoire dans les économies émergentes alimentent la croissance du tourisme médical, stimulant ainsi le marché des dispositifs de valves cardiaques. Le besoin de procédures mini-invasives pour traiter les anomalies cardiaques a considérablement augmenté. Les applications actuelles de l'automatisation dans la chirurgie des valves cardiaques, comme le remplacement de la valve aortique par voie transcathéter (TAVR), ont donné lieu à une variété croissante d'interventions similaires. À en juger par la proportion croissante de la population vieillissante, l'augmentation des polices d'assurance-vie devrait également contribuer à la croissance du marché des valves cardiaques.
Dynamique du marché mondial des dispositifs de valve cardiaque
Cette section traite de la compréhension des moteurs, des avantages, des opportunités, des contraintes et des défis du marché. Tout cela est discuté en détail ci-dessous :
Conducteurs
- Les innovations dans le domaine des dispositifs de valve cardiaque offrent de meilleurs résultats cliniques
Le lancement de nouveaux produits pour les procédures mini-invasives devrait stimuler le marché mondial des dispositifs de valve cardiaque. Les valves tissulaires ont révolutionné le marché des valves cardiaques. La prochaine génération de chirurgie des valves cardiaques offre moins de courbes de pose, un placement plus contrôlé, une fonction valvulaire améliorée, une régurgitation valvulaire réduite, une durabilité accrue et un coût réduit. L'innovation des produits a stimulé les perspectives de croissance des acteurs du marché des dispositifs de valve cardiaque, car elle permet de traiter un plus grand nombre de patients avec des résultats cliniques supérieurs. Malgré des avancées significatives ces dernières années, la cardiologie interventionnelle structurelle reste un marché émergent avec un grand potentiel.
De plus, les conceptions intelligentes, les nouvelles technologies et les applications de biomatériaux continuent de repousser les limites du développement de nouveaux produits, garantissant que ces dispositifs seront à la pointe de l'innovation en matière de produits interventionnels pour les années à venir. Les innovations en matière de conception aident les acteurs du marché à exploiter des opportunités de croissance rentables dans le domaine des dispositifs de valve cardiaque.
Ainsi, la croissance du marché mondial des dispositifs de valves cardiaques devrait être propulsée en raison de l’augmentation des innovations dans ce domaine.
- Augmentation du nombre de diverses maladies cardiaques
Les crises cardiaques et les accidents vasculaires cérébraux sont généralement des événements aigus et sont principalement causés par un blocage qui bloque le flux sanguin vers le cœur ou le cerveau. Au cours de la première année de la pandémie de COVID-19, les décès dus aux maladies cardiaques et aux accidents vasculaires cérébraux ont augmenté respectivement de 5,8 % et de 6,8 %. Cependant, les augmentations liées à l’âge ont été de 1,6 % et de 1,7 % pour les maladies cardiaques et les accidents vasculaires cérébraux, respectivement. La cause la plus courante est l’accumulation de dépôts graisseux dans la paroi des vaisseaux sanguins qui alimentent le cœur ou le cerveau. Un accident vasculaire cérébral peut être causé par un saignement ou des caillots sanguins dans un vaisseau sanguin du cerveau. Cette tendance suggère que l’incidence des maladies cardiovasculaires pourrait augmenter considérablement en raison de la croissance démographique et du vieillissement.
De plus, un diabète élevé, une pression artérielle élevée, un taux de cholestérol élevé et le tabagisme sont des facteurs de risque majeurs de maladie cardiaque. Environ la moitié des Américains (47 %) présentent au moins un de ces trois facteurs de risque. D’autres problèmes de santé et choix de vie peuvent également augmenter le risque de maladie cardiaque, notamment une alimentation malsaine, l’inactivité physique et la consommation excessive d’alcool.
De plus, le nombre croissant de maladies cardiaques devrait agir comme un moteur pour le marché mondial des dispositifs de valves cardiaques.
Opportunité
- Sensibilisation accrue aux prothèses
A prosthesis is a device designed to replace a missing body part or to improve the function of a body part. Prosthetic heart valves are increasingly used in cases of abnormalities of the natural valves that require intervention. Generally, they can be divided into mechanical heart valves, biological valves, and allogeneic grafts. The goal of artificial valves is to act hemodynamically like a natural valve with minimal side effects. Cardiovascular prostheses devices have been developed to replace damaged heart tissue. These medical devices are designed to mimic the function of normal cardiovascular organs. Artificial hearts allow heart surgeons to increase the treatment of heart blocks.
Moreover, the prevalence of prosthetic valves ranges from 0.2 per 1,000 in people years of age or younger to 5.3 in people years of age or younger.
Thus the increasing awareness about prosthetic devices acts as an opportunity for the market's growth.
Restraint/Challenge
- Expensive Production Cost of Equipment
The number of patients treated for aortic valve disease in the United States is growing quickly. Transcatheter aortic valve replacement (TAVR) replaces surgical aortic valve replacement (SAVR) and medical treatment (M.T.). The economic consequences of these trends are unknown. Therefore, the total cost of TAVR is higher than SAVR and much more expensive than M.T. alone. TAVR costs have decreased over time, while SAVR and M.T. costs have remained the same.
In addition, the high surgical cost of TAVI is mainly due to the high cost of the production. However, due to the shorter hospital stay, the cost of non-surgical TAVI is lower compared to AVR. The cost of the TAVI implant kit alone (valve, balloon, sheath) is $32,500, while the surgical valve only costs about $5,000, just like in Switzerland, the TAVI implant set costs about 32,000 francs (around of $35,000), while the cost of a biosurgical prosthesis is about 3,000 Swiss francs (about US$3,300). Depending on comorbidities and complications, reimbursement in the United States is between $ 0,000 and $ 5,000, TAVI in Switzerland is about 72,000 francs ($78,000), and AVR is about 3,000 francs ($ 7,000), which means a financial loss for the hospital.
Thus, the rising production cost of equipment may hamper the market's growth.
Recent Developments
- In September 2023, Abbott released data from five late-stage presentations showing the benefits of its minimally invasive devices in treating people with various structural heart diseases. The data includes findings that support the value of MitraClip™. It is the world's first and leading transcatheter edge-to-edge repair (TEER) to treat leaky valves in people with mitral regurgitation (MR). New data on Abbott's structural heart therapies were presented at the Cardiovascular Research Foundation's 34th Annual Transcatheter Cardiovascular Therapy (TCT) Scientific Symposium in Boston. This has helped the company to increase its business position in the market.
- In September 2020, Boston Scientific Corporation announced that it had introduced a controlled launch of the ACURATE neo2™ aortic valve system in Europe. This next-generation transcatheter aortic valve implantation (TAVI) technology is a new platform designed with multiple features to improve the clinical performance of the original ACURATE new platform. Compared to the previous generation, the ACURATE neo2 valve system has an expanded indication for patients with aortic stenosis. This has helped the company to gain its product portfolio.
Global Heart Valve Devices Market Scope
The heart valve devices market is segmented into product type, treatment, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
BY PRODUCT TYPE
- Mechanical Heart Valves
- Biological Heart Valves
- Transcatheter Valves
On the basis of product type, the heart valve devices market is segmented into mechanical heart valves, biological heart valves and transcatheter valves.
BY TREATMENT
- OPEN SURGERY
- MINIMALLY INVASIVE SURGERY
On the basis of treatment, the heart valve devices market is segmented into open surgery and minimally invasive surgery.
BY END USER
- HOSPITAL & CLINICS
- AMBULATORY SURGICAL CENTERS
- CARDIAC CENTERS
- RESEARCH CENTERS
- OTHERS
On the basis of end user, the heart valve devices market is segmented into hospitals & clinics, ambulatory surgical centers, cardiac centers, research centers and others.
BY DISTRIBUTION CHANNEL
- DIRECT TENDER
- THIRD PARTY DISTRIBUTORS
On the basis of distribution channel, the heart valve devices market is segmented into direct tender and third party distributors.
Global Heart Valve Devices Market Regional Analysis/Insights
The heart valve devices market is analyzed and market size information is provided product type, treatment, end user, and distribution channel.
The countries covered in this market report U.S., Canada, Mexico, Germany, France, U.K., Italy, Russia, Spain, Netherlands, Switzerland, Norway, Poland, Sweden, Belgium, Turkey, Denmark, Finland and the rest of Europe, China, Japan, India, Australia, New Zealand, South Korea, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Taiwan and the rest of Asia-Pacific, South Africa, Saudi Arabia, Bahrain, UAE, Kuwait, Oman, Qatar Israel, Egypt, and the rest of Middle East and Africa, Brazil, Argentina, and the rest of South America.
North America is dominating the market due to the increasing investment in R&D. The U.S. dominates North America region due to strong presence of key players. Germany dominates Europe region due to the mass production of heart valve devices and increasing demand from emerging markets and expansion of healthcare industries. China dominates Asia-Pacific region due to rise in availability of heart valve disease related surgery devices.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Heart Valve Devices Market Share Analysis
The heart valve devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus on the heart valve devices market.
Some of the key players operating in the heart valve devices market are Abbott, Boston Scientific Corporation or its affiliates, Artivion, Inc., Edwards Lifesciences Corporation, Medtronic, NeoVasc, Micro Interventional Devices Incorporated, XELTIS, TTK, Meril Life Sciences Pvt. Ltd, Foldax, Inc., Venus Medtech (Hangzhou) Inc., Colibri Heart Valve among others.
Research Methodology: Global Heart Valve Devices Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global vs Regional, and Vendor Share Analysis. Please request analyst call in case of further inquiry.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE GLOBAL HEART VALVE DEVICES MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 SOURCE LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 EPIDEMIOLOGY
3.2 PESTEL ANALYSIS
3.3 PORTER'S FIVE FORCE
4 MARKET OVERVIEW
4.1 DRIVERS
4.1.1 INNOVATIONS IN HEART VALVE DEVICES OFFER IMPROVED CLINICAL OUTCOME
4.1.2 RISING NUMBER OF VARIOUS HEART DISEASES
4.1.3 ADVANCEMENTS IN TRANSCATHETER VALVE TECHNOLOGY
4.1.4 INCREASING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES
4.2 RESTRAINTS
4.2.1 HIGH COST ASSOCIATED WITH THE SURGERIES
4.2.2 COMPLICATIONS ASSOCIATED WITH HEART VALVE REPLACEMENT
4.3 OPPORTUNITIES
4.3.1 INCREASING AWARENESS OF PROSTHETIC DEVICES
4.3.2 RISING PREVALENCE OF STROKE & CARDIAC ARREST TO REINFORCE DEMAND FOR HEART VALVE DEVICES
4.3.3 INCREASING FDA APPROVALS OF TRANSCATHETER AORTIC VALVES
4.4 CHALLENGES
4.4.1 STRICT GOVERNMENT REGULATIONS
4.4.2 EXPENSIVE PRODUCTION COST OF EQUIPMENT
5 GLOBAL HEART VALVE DEVICES MARKET, BY PRODUCT TYPE
5.1 OVERVIEW
5.2 MECHANICAL HEART VALVES
5.2.1 AORTIC VALVE
5.2.2 MITRAL VALVE
5.3 BIOLOGICAL HEART VALVES
5.3.1 AORTIC VALVE
5.3.2 MITRAL VALVE
5.3.3 PULMONARY VALVE
5.3.4 TRICUSPID VALVE
5.4 TRANSCATHETER VALVE
5.4.1 AORTIC VALVE
5.4.2 MITRAL VALVE
5.4.3 PULMONARY VALVE
6 GLOBAL HEART VALVE DEVICES MARKET, BY TREATMENT
6.1 OVERVIEW
6.2 MINIMALLY INVASIVE SURGERY (MIS)
6.2.1 CARDIAC VALVE REPLACEMENT
6.2.2 CARDIAC VALVE REPAIR
6.3 OPEN SURGERY
6.3.1 CARDIAC VALVE REPLACEMENT
6.3.2 CARDIAC VALVE REPAIR
7 GLOBAL HEART VALVE DEVICES MARKET, BY END USER
7.1 OVERVIEW
7.2 HOSPITAL & CLINICS
7.3 AMBULATORY SURGICAL CENTERS
7.4 CARDIAC CENTERS
7.5 RESEARCH CENTERS
7.6 OTHERS
8 GLOBAL HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL
8.1 OVERVIEW
8.2 DIRECT TENDER
8.3 THIRD PARTY DISTRIBUTORS
9 GLOBAL HEART VALVE DEVICES MARKET, BY REGION
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 U.S.
9.2.2 CANADA
9.2.3 MEXICO
9.3 SOUTH AMERICA
9.3.1 BRAZIL
9.3.2 ARGENTINA
9.3.3 REST OF SOUTH AMERICA
9.4 EUROPE
9.4.1 GERMANY
9.4.2 FRANCE
9.4.3 U.K.
9.4.4 ITALY
9.4.5 RUSSIA
9.4.6 SPAIN
9.4.7 TURKEY
9.4.8 NETHERLANDS
9.4.9 SWITZERLAND
9.4.10 BELGIUM
9.4.11 DENMARK
9.4.12 SWEDEN
9.4.13 POLAND
9.4.14 NORWAY
9.4.15 FINLAND
9.4.16 REST OF EUROPE
9.5 ASIA-PACIFIC
9.5.1 CHINA
9.5.2 JAPAN
9.5.3 SOUTH KOREA
9.5.4 INDIA
9.5.5 AUSTRALIA
9.5.6 SINGAPORE
9.5.7 TAIWAN
9.5.8 THAILAND
9.5.9 MALAYSIA
9.5.10 INDONESIA
9.5.11 PHILIPPINES
9.5.12 NEW ZEALAND
9.5.13 VIETNAM
9.5.14 REST OF ASIA-PACIFIC
9.6 MIDDLE EAST AND AFRICA
9.6.1 SOUTH AFRICA
9.6.2 SAUDI ARABIA
9.6.3 U.A.E.
9.6.4 EGYPT
9.6.5 ISRAEL
9.6.6 KUWAIT
9.6.7 QATAR
9.6.8 OMAN
9.6.9 BAHRAIN
9.6.10 REST OF MIDDLE EAST AND AFRICA
10 GLOBAL HEART VALVE DEVICES MARKET: COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS: GLOBAL
10.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
10.3 COMPANY SHARE ANALYSIS: EUROPE
10.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
11 SWOT ANALYSIS
12 COMPANY PROFILE
12.1 MEDTRONIC
12.1.1 COMPANY SNAPSHOT
12.1.2 REVENUE ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENTS
12.2 EDWARDS LIFESCIENCES CORPORATION
12.2.1 COMPANY SNAPSHOT
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENTS
12.3 ABBOTT
12.3.1 COMPANY SNAPSHOT
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHARE ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENTS
12.4 BOSTON SCIENTIFIC CORPORATION OR ITS AFFILIATES.
12.4.1 COMPANY SNAPSHOT
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHARE ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENT
12.5 ARTIVION, INC.
12.5.1 COMPANY SNAPSHOT
12.5.2 REVENUE ANALYSIS
12.5.3 COMPANY SHARE ANALYSIS
12.5.4 PRODUCT PORTFOLIO
12.5.5 RECENT DEVELOPMENTS
12.6 COLIBRI HEART VALVE
12.6.1 COMPANY SNAPSHOT
12.6.2 PRODUCT PORTFOLIO
12.6.3 RECENT DEVELOPMENTS
12.7 FOLDAX, INC.
12.7.1 COMPANY SNAPSHOT
12.7.2 PRODUCT PORTFOLIO
12.7.3 RECENT DEVELOPMENTS
12.8 MERIL LIFE SCIENCES PVT. LTD.
12.8.1 COMPANY SNAPSHOT
12.8.2 PRODUCT PORTFOLIO
12.8.3 RECENT DEVELOPMENTS
12.9 MICRO INTERVENTIONAL DEVICES, INCORPORATED.
12.9.1 COMPANY SNAPSHOT
12.9.2 PRODUCT PORTFOLIO
12.9.3 RECENT DEVELOPMENTS
12.1 NEOVASC
12.10.1 COMPANY SNAPSHOT
12.10.2 REVENUE ANALYSIS
12.10.3 PRODUCT PORTFOLIO
12.10.4 RECENT DEVELOPMENTS
12.11 TTK
12.11.1 COMPANY SNAPSHOT
12.11.2 REVENUE ANALYSIS
12.11.3 PRODUCT PORTFOLIO
12.11.4 RECENT DEVELOPMENTS
12.12 VENUS MEDTECH (HANGZHOU) INC.
12.12.1 COMPANY SNAPSHOT
12.12.2 REVENUE ANALYSIS
12.12.3 PRODUCT PORTFOLIO
12.12.4 RECENT DEVELOPMENTS
12.13 XELTIS
12.13.1 COMPANY SNAPSHOT
12.13.2 PRODUCT PORTFOLIO
12.13.3 RECENT DEVELOPMENTS
13 QUESTIONNAIRE
14 RELATED REPORTS
Liste des tableaux
TABLE 1 GLOBAL HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 2 GLOBAL MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 GLOBAL MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 4 GLOBAL BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 5 GLOBAL BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 6 GLOBAL TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 7 GLOBAL TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 8 GLOBAL HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 9 GLOBAL MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 10 GLOBAL MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 11 GLOBAL OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 12 GLOBAL OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 13 GLOBAL HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 14 GLOBAL HOSPITALS & CLINICS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 GLOBAL AMBULATORY SURGICAL CENTERS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 16 GLOBAL CARDIAC CENTERS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 GLOBAL RESEARCH CENTERS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 18 GLOBAL OTHERS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 GLOBAL HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 20 GLOBAL DIRECT TENDER IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 21 GLOBAL THIRD PARTY DISTRIBUTORS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 22 GLOBAL HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 23 NORTH AMERICA HEART VALVE DEVICES MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 24 NORTH AMERICA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 25 NORTH AMERICA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 26 NORTH AMERICA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 27 NORTH AMERICA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 28 NORTH AMERICA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 29 NORTH AMERICA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 30 NORTH AMERICA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 31 NORTH AMERICA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 32 NORTH AMERICA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 33 U.S. HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 34 U.S. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 35 U.S. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 36 U.S. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 37 U.S. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 38 U.S. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 39 U.S. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 40 U.S. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 41 U.S. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 42 U.S. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 43 U.S. HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 44 U.S. MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 45 U.S. OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 46 U.S. HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 47 U.S. HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 48 CANADA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 49 CANADA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 50 CANADA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 51 CANADA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 52 CANADA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 53 CANADA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 54 CANADA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 55 CANADA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 56 CANADA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 57 CANADA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 58 CANADA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 59 CANADA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 60 CANADA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 61 CANADA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 62 CANADA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 63 MEXICO HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 64 MEXICO MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 65 MEXICO MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 66 MEXICO MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 67 MEXICO BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 68 MEXICO BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 69 MEXICO BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 70 MEXICO TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 71 MEXICO TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 72 MEXICO TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 73 MEXICO HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 74 MEXICO MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 75 MEXICO OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 76 MEXICO HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 77 MEXICO HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 78 SOUTH AMERICA HEART VALVE DEVICES MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 79 SOUTH AMERICA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 80 SOUTH AMERICA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 81 SOUTH AMERICA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 82 SOUTH AMERICA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 83 SOUTH AMERICA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 84 SOUTH AMERICA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 85 SOUTH AMERICA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 86 SOUTH AMERICA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 87 SOUTH AMERICA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 88 BRAZIL HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 89 BRAZIL MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 90 BRAZIL MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 91 BRAZIL MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 92 BRAZIL BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 93 BRAZIL BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 94 BRAZIL BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 95 BRAZIL TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 96 BRAZIL TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 97 BRAZIL TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 98 BRAZIL HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 99 BRAZIL MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 100 BRAZIL OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 101 BRAZIL HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 102 BRAZIL HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 103 ARGENTINA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 104 ARGENTINA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 105 ARGENTINA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 106 ARGENTINA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 107 ARGENTINA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 108 ARGENTINA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 109 ARGENTINA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 110 ARGENTINA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 111 ARGENTINA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 112 ARGENTINA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 113 ARGENTINA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 114 ARGENTINA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 115 ARGENTINA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 116 ARGENTINA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 117 ARGENTINA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 118 REST OF SOUTH AMERICA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 119 EUROPE HEART VALVE DEVICES MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 120 EUROPE HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 121 EUROPE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 122 EUROPE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 123 EUROPE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 124 EUROPE HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 125 EUROPE MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 126 EUROPE OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 127 EUROPE HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 128 EUROPE HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 129 GERMANY HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 130 GERMANY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 131 GERMANY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 132 GERMANY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 133 GERMANY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 134 GERMANY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 135 GERMANY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 136 GERMANY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 137 GERMANY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 138 GERMANY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 139 GERMANY HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 140 GERMANY MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 141 GERMANY OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 142 GERMANY HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 143 GERMANY HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 144 FRANCE HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 145 FRANCE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 146 FRANCE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 147 FRANCE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 148 FRANCE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 149 FRANCE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 150 FRANCE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 151 FRANCE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 152 FRANCE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 153 FRANCE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 154 FRANCE HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 155 FRANCE MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 156 FRANCE OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 157 FRANCE HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 158 FRANCE HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 159 U.K. HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 160 U.K. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 161 U.K. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 162 U.K. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 163 U.K. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 164 U.K. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 165 U.K. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 166 U.K. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 167 U.K. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 168 U.K. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 169 U.K. HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 170 U.K. MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 171 U.K. OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 172 U.K. HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 173 U.K. HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 174 ITALY HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 175 ITALY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 176 ITALY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 177 ITALY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 178 ITALY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 179 ITALY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 180 ITALY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 181 ITALY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 182 ITALY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 183 ITALY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 184 ITALY HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 185 ITALY MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 186 ITALY OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 187 ITALY HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 188 ITALY HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 189 RUSSIA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 190 RUSSIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 191 RUSSIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 192 RUSSIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 193 RUSSIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 194 RUSSIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 195 RUSSIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 196 RUSSIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 197 RUSSIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 198 RUSSIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 199 RUSSIA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 200 RUSSIA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 201 RUSSIA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 202 RUSSIA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 203 RUSSIA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 204 SPAIN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 205 SPAIN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 206 SPAIN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 207 SPAIN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 208 SPAIN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 209 SPAIN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 210 SPAIN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 211 SPAIN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 212 SPAIN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 213 SPAIN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 214 SPAIN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 215 SPAIN MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 216 SPAIN OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 217 SPAIN HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 218 SPAIN HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 219 TURKEY HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 220 TURKEY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 221 TURKEY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 222 TURKEY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 223 TURKEY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 224 TURKEY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 225 TURKEY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 226 TURKEY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 227 TURKEY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 228 TURKEY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 229 TURKEY HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 230 TURKEY MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 231 TURKEY OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 232 TURKEY HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 233 TURKEY HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 234 NETHERLANDS HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 235 NETHERLANDS MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 236 NETHERLANDS MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 237 NETHERLANDS MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 238 NETHERLANDS BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 239 NETHERLANDS BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 240 NETHERLANDS BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 241 NETHERLANDS TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 242 NETHERLANDS TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 243 NETHERLANDS TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 244 NETHERLANDS HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 245 NETHERLANDS MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 246 NETHERLANDS OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 247 NETHERLANDS HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 248 NETHERLANDS HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 249 SWITZERLAND HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 250 SWITZERLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 251 SWITZERLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 252 SWITZERLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 253 SWITZERLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 254 SWITZERLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 255 SWITZERLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 256 SWITZERLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 257 SWITZERLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 258 SWITZERLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 259 SWITZERLAND HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 260 SWITZERLAND MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 261 SWITZERLAND OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 262 SWITZERLAND HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 263 SWITZERLAND HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 264 BELGIUM HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 265 BELGIUM MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 266 BELGIUM MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 267 BELGIUM MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 268 BELGIUM BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 269 BELGIUM BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 270 BELGIUM BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 271 BELGIUM TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 272 BELGIUM TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 273 BELGIUM TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 274 BELGIUM HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 275 BELGIUM MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 276 BELGIUM OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 277 BELGIUM HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 278 BELGIUM HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 279 DENMARK HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 280 DENMARK MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 281 DENMARK MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 282 DENMARK MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 283 DENMARK BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 284 DENMARK BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 285 DENMARK BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 286 DENMARK TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 287 DENMARK TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 288 DENMARK TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 289 DENMARK HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 290 DENMARK MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 291 DENMARK OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 292 DENMARK HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 293 DENMARK HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 294 SWEDEN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 295 SWEDEN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 296 SWEDEN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 297 SWEDEN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 298 SWEDEN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 299 SWEDEN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 300 SWEDEN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 301 SWEDEN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 302 SWEDEN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 303 SWEDEN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 304 SWEDEN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 305 SWEDEN MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 306 SWEDEN OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 307 SWEDEN HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 308 SWEDEN HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 309 POLAND HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 310 POLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 311 POLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 312 POLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 313 POLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 314 POLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 315 POLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 316 POLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 317 POLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 318 POLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 319 POLAND HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 320 POLAND MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 321 POLAND OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 322 POLAND HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 323 POLAND HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 324 NORWAY HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 325 NORWAY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 326 NORWAY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 327 NORWAY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 328 NORWAY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 329 NORWAY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 330 NORWAY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 331 NORWAY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 332 NORWAY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 333 NORWAY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 334 NORWAY HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 335 NORWAY MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 336 NORWAY OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 337 NORWAY HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 338 NORWAY HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 339 FINLAND HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 340 FINLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 341 FINLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 342 FINLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 343 FINLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 344 FINLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 345 FINLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 346 FINLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 347 FINLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 348 FINLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 349 FINLAND HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 350 FINLAND MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 351 FINLAND OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 352 FINLAND HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 353 FINLAND HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 354 REST OF EUROPE HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 355 ASIA-PACIFIC HEART VALVE DEVICES MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 356 ASIA-PACIFIC HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 357 ASIA-PACIFIC MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 358 ASIA-PACIFIC BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 359 ASIA-PACIFIC TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 360 ASIA-PACIFIC HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 361 ASIA-PACIFIC MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 362 ASIA-PACIFIC OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 363 ASIA-PACIFIC HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 364 ASIA-PACIFIC HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 365 CHINA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 366 CHINA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 367 CHINA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 368 CHINA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 369 CHINA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 370 CHINA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 371 CHINA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 372 CHINA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 373 CHINA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 374 CHINA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 375 CHINA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 376 CHINA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 377 CHINA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 378 CHINA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 379 CHINA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 380 JAPAN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 381 JAPAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 382 JAPAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 383 JAPAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 384 JAPAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 385 JAPAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 386 JAPAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 387 JAPAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 388 JAPAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 389 JAPAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 390 JAPAN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 391 JAPAN MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 392 JAPAN OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 393 JAPAN HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 394 JAPAN HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 395 SOUTH KOREA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 396 SOUTH KOREA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 397 SOUTH KOREA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 398 SOUTH KOREA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 399 SOUTH KOREA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 400 SOUTH KOREA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 401 SOUTH KOREA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 402 SOUTH KOREA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 403 SOUTH KOREA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 404 SOUTH KOREA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 405 SOUTH KOREA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 406 SOUTH KOREA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 407 SOUTH KOREA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 408 SOUTH KOREA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 409 SOUTH KOREA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 410 INDIA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 411 INDIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 412 INDIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 413 INDIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 414 INDIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 415 INDIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 416 INDIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 417 INDIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 418 INDIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 419 INDIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 420 INDIA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 421 INDIA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 422 INDIA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 423 INDIA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 424 INDIA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 425 AUSTRALIA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 426 AUSTRALIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 427 AUSTRALIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 428 AUSTRALIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 429 AUSTRALIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 430 AUSTRALIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 431 AUSTRALIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 432 AUSTRALIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 433 AUSTRALIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 434 AUSTRALIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 435 AUSTRALIA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 436 AUSTRALIA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 437 AUSTRALIA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 438 AUSTRALIA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 439 AUSTRALIA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 440 SINGAPORE HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 441 SINGAPORE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 442 SINGAPORE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 443 SINGAPORE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 444 SINGAPORE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 445 SINGAPORE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 446 SINGAPORE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 447 SINGAPORE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 448 SINGAPORE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 449 SINGAPORE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 450 SINGAPORE HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 451 SINGAPORE MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 452 SINGAPORE OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 453 SINGAPORE HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 454 SINGAPORE HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 455 TAIWAN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 456 TAIWAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 457 TAIWAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 458 TAIWAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 459 TAIWAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 460 TAIWAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 461 TAIWAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 462 TAIWAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 463 TAIWAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 464 TAIWAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 465 TAIWAN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 466 TAIWAN MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 467 TAIWAN OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 468 TAIWAN HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 469 TAIWAN HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 470 THAILAND HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 471 THAILAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 472 THAILAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 473 THAILAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 474 THAILAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 475 THAILAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 476 THAILAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 477 THAILAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 478 THAILAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 479 THAILAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 480 THAILAND HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 481 THAILAND MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 482 THAILAND OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 483 THAILAND HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 484 THAILAND HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 485 MALAYSIA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 486 MALAYSIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 487 MALAYSIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 488 MALAYSIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 489 MALAYSIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 490 MALAYSIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 491 MALAYSIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 492 MALAYSIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 493 MALAYSIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 494 MALAYSIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 495 MALAYSIA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 496 MALAYSIA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 497 MALAYSIA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 498 MALAYSIA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 499 MALAYSIA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 500 INDONESIA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 501 INDONESIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 502 INDONESIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 503 INDONESIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 504 INDONESIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 505 INDONESIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 506 INDONESIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 507 INDONESIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 508 INDONESIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 509 INDONESIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 510 INDONESIA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 511 INDONESIA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 512 INDONESIA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 513 INDONESIA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 514 INDONESIA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 515 PHILIPPINES HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 516 PHILIPPINES MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 517 PHILIPPINES MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 518 PHILIPPINES MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 519 PHILIPPINES BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 520 PHILIPPINES BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 521 PHILIPPINES BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 522 PHILIPPINES TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 523 PHILIPPINES TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 524 PHILIPPINES TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 525 PHILIPPINES HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 526 PHILIPPINES MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 527 PHILIPPINES OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 528 PHILIPPINES HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 529 PHILIPPINES HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 530 NEW ZEALAND HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 531 NEW ZEALAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 532 NEW ZEALAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 533 NEW ZEALAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 534 NEW ZEALAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 535 NEW ZEALAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 536 NEW ZEALAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 537 NEW ZEALAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 538 NEW ZEALAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 539 NEW ZEALAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 540 NEW ZEALAND HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 541 NEW ZEALAND MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 542 NEW ZEALAND OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 543 NEW ZEALAND HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 544 NEW ZEALAND HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 545 VIETNAM HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 546 VIETNAM MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 547 VIETNAM MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 548 VIETNAM MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 549 VIETNAM BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 550 VIETNAM BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 551 VIETNAM BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 552 VIETNAM TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 553 VIETNAM TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 554 VIETNAM TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 555 VIETNAM HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 556 VIETNAM MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 557 VIETNAM OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 558 VIETNAM HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 559 VIETNAM HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 560 REST OF ASIA-PACIFIC HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 561 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 562 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 563 MIDDLE EAST AND AFRICA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 564 MIDDLE EAST AND AFRICA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 565 MIDDLE EAST AND AFRICA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 566 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 567 MIDDLE EAST AND AFRICA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 568 MIDDLE EAST AND AFRICA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 569 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 570 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 571 SOUTH AFRICA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 572 SOUTH AFRICA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 573 SOUTH AFRICA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 574 SOUTH AFRICA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 575 SOUTH AFRICA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 576 SOUTH AFRICA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 577 SOUTH AFRICA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 578 SOUTH AFRICA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 579 SOUTH AFRICA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 580 SOUTH AFRICA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 581 SOUTH AFRICA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 582 SOUTH AFRICA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 583 SOUTH AFRICA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 584 SOUTH AFRICA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 585 SOUTH AFRICA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 586 SAUDI ARABIA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 587 SAUDI ARABIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 588 SAUDI ARABIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 589 SAUDI ARABIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 590 SAUDI ARABIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 591 SAUDI ARABIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 592 SAUDI ARABIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 593 SAUDI ARABIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 594 SAUDI ARABIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 595 SAUDI ARABIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 596 SAUDI ARABIA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 597 SAUDI ARABIA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 598 SAUDI ARABIA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 599 SAUDI ARABIA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 600 SAUDI ARABIA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 601 U.A.E. HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 602 U.A.E. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 603 U.A.E. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 604 U.A.E. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 605 U.A.E. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 606 U.A.E. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 607 U.A.E. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 608 U.A.E. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 609 U.A.E. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 610 U.A.E. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 611 U.A.E. HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 612 U.A.E. MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 613 U.A.E. OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 614 U.A.E. HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 615 U.A.E. HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 616 EGYPT HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 617 EGYPT MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 618 EGYPT MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 619 EGYPT MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 620 EGYPT BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 621 EGYPT BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 622 EGYPT BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 623 EGYPT TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 624 EGYPT TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 625 EGYPT TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 626 EGYPT HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 627 EGYPT MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 628 EGYPT OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 629 EGYPT HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 630 EGYPT HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 631 ISRAEL HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 632 ISRAEL MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 633 ISRAEL MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 634 ISRAEL MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 635 ISRAEL BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 636 ISRAEL BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 637 ISRAEL BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 638 ISRAEL TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 639 ISRAEL TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 640 ISRAEL TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 641 ISRAEL HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 642 ISRAEL MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 643 ISRAEL OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 644 ISRAEL HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 645 ISRAEL HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 646 KUWAIT HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 647 KUWAIT MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 648 KUWAIT MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 649 KUWAIT MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 650 KUWAIT BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 651 KUWAIT BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 652 KUWAIT BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 653 KUWAIT TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 654 KUWAIT TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 655 KUWAIT TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 656 KUWAIT HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 657 KUWAIT MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 658 KUWAIT OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 659 KUWAIT HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 660 KUWAIT HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 661 QATAR HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 662 QATAR MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 663 QATAR MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 664 QATAR MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 665 QATAR BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 666 QATAR BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 667 QATAR BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 668 QATAR TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 669 QATAR TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 670 QATAR TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 671 QATAR HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 672 QATAR MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 673 QATAR OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 674 QATAR HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 675 QATAR HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 676 OMAN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 677 OMAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 678 OMAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 679 OMAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 680 OMAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 681 OMAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 682 OMAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 683 OMAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 684 OMAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 685 OMAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 686 OMAN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 687 OMAN MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 688 OMAN OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 689 OMAN HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 690 OMAN HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 691 BAHRAIN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 692 BAHRAIN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 693 BAHRAIN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 694 BAHRAIN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 695 BAHRAIN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 696 BAHRAIN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 697 BAHRAIN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 698 BAHRAIN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 699 BAHRAIN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 700 BAHRAIN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 701 BAHRAIN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 702 BAHRAIN MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 703 BAHRAIN OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 704 BAHRAIN HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 705 BAHRAIN HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 706 REST OF MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
Liste des figures
FIGURE 1 GLOBAL HEART VALVE DEVICES MARKET: SEGMENTATION
FIGURE 2 GLOBAL HEART VALVE DEVICES MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL HEART VALVE DEVICES MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL HEART VALVE DEVICES MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL HEART VALVE DEVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL HEART VALVE DEVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL HEART VALVE DEVICES MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 GLOBAL HEART VALVE DEVICES MARKET: DBMR MARKET POSITION GRID
FIGURE 9 GLOBAL HEART VALVE DEVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL HEART VALVE DEVICES MARKET: SEGMENTATION
FIGURE 11 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE GLOBAL HEART VALVE DEVICES MARKET, AND ASIA-PACIFIC IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD
FIGURE 12 GROWING PREVALENCE OF VALVULAR DISEASES, SUCH AS AORTIC STENOSIS & AORTIC REGURGITATION, AND INCREASING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES ARE EXPECTED TO DRIVE THE GLOBAL HEART VALVE DEVICES MARKET IN THE FORECAST PERIOD
FIGURE 13 MECHANICAL HEART VALVE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL HEART VALVE DEVICES MARKET IN 2023 & 2030
FIGURE 14 NORTH AMERICA IS THE FASTEST GROWING MARKET FOR HEART VALVE DEVICES MANUFACTURERS IN THE FORECAST PERIOD
FIGURE 15 INCIDENDE AND PREVALENCE OF HEART VALVE OF NORTH AMERICA
FIGURE 16 INCIDENDE AND PREVALENCE OF HEART VALVE OF EUROPE
FIGURE 17 INCIDENDE AND PREVALENCE OF HEART VALVE OF ASIA-PACIFIC
FIGURE 18 INCIDENDE AND PREVALENCE OF HEART VALVE OF SOUTH AMERICA & MIDDLE EAST AND AFRICA
FIGURE 19 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL HEART VALVE DEVICES MARKET
FIGURE 20 GLOBAL HEART VALVE DEVICES MARKET : BY PRODUCT TYPE, 2022
FIGURE 21 GLOBAL HEART VALVE DEVICES MARKET : BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 22 GLOBAL HEART VALVE DEVICES MARKET : BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 23 GLOBAL HEART VALVE DEVICES MARKET : BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 24 GLOBAL HEART VALVE DEVICES MARKET : BY TREATMENT, 2022
FIGURE 25 GLOBAL HEART VALVE DEVICES MARKET : BY TREATMENT, 2023-2030 (USD MILLION)
FIGURE 26 GLOBAL HEART VALVE DEVICES MARKET : BY TREATMENT, CAGR (2023-2030)
FIGURE 27 GLOBAL HEART VALVE DEVICES MARKET : BY TREATMENT, LIFELINE CURVE
FIGURE 28 GLOBAL HEART VALVE DEVICES MARKET : BY END USER, 2022
FIGURE 29 GLOBAL HEART VALVE DEVICES MARKET : BY END USER, 2023-2030 (USD MILLION)
FIGURE 30 GLOBAL HEART VALVE DEVICES MARKET : BY END USER, CAGR (2023-2030)
FIGURE 31 GLOBAL HEART VALVE DEVICES MARKET : BY END USER, LIFELINE CURVE
FIGURE 32 GLOBAL HEART VALVE DEVICES MARKET : BY DISTRIBUTION CHANNEL, 2022
FIGURE 33 GLOBAL HEART VALVE DEVICES MARKET : BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 34 GLOBAL HEART VALVE DEVICES MARKET : BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 35 GLOBAL HEART VALVE DEVICES MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 36 GLOBAL HEART VALVE DEVICES MARKET: SNAPSHOT (2022)
FIGURE 37 GLOBAL HEART VALVE DEVICES MARKET: BY REGION (2022)
FIGURE 38 GLOBAL HEART VALVE DEVICES MARKET: BY REGION (2023 & 2030)
FIGURE 39 GLOBAL HEART VALVE DEVICES MARKET: BY REGION (2022 & 2030)
FIGURE 40 GLOBAL HEART VALVE DEVICES MARKET: BY PRODUCT TYPE (2023-2030)
FIGURE 41 NORTH AMERICA HEART VALVE DEVICES MARKET: SNAPSHOT (2022)
FIGURE 42 NORTH AMERICA HEART VALVE DEVICES MARKET: BY COUNTRY (2022)
FIGURE 43 NORTH AMERICA HEART VALVE DEVICES MARKET: BY COUNTRY (2023 & 2030)
FIGURE 44 NORTH AMERICA HEART VALVE DEVICES MARKET: BY COUNTRY (2022 & 2030)
FIGURE 45 NORTH AMERICA HEART VALVE DEVICES MARKET: BY PRODUCT TYPE (2023-2030)
FIGURE 46 SOUTH AMERICA HEART VALVE DEVICES MARKET: SNAPSHOT (2022)
FIGURE 47 SOUTH AMERICA HEART VALVE DEVICES MARKET: BY COUNTRY (2022)
FIGURE 48 SOUTH AMERICA HEART VALVE DEVICES MARKET: BY COUNTRY (2023 & 2030)
FIGURE 49 SOUTH AMERICA HEART VALVE DEVICES MARKET: BY COUNTRY (2022 & 2030)
FIGURE 50 SOUTH AMERICA HEART VALVE DEVICES MARKET: BY PRODUCT TYPE (2023-2030)
FIGURE 51 EUROPE HEART VALVE DEVICES MARKET: SNAPSHOT (2022)
FIGURE 52 EUROPE HEART VALVE DEVICES MARKET: BY COUNTRY (2022)
FIGURE 53 EUROPE HEART VALVE DEVICES MARKET: BY COUNTRY (2023 & 2030)
FIGURE 54 EUROPE HEART VALVE DEVICES MARKET: BY COUNTRY (2022 & 2030)
FIGURE 55 EUROPE HEART VALVE DEVICES MARKET: BY PRODUCT TYPE (2023-2030)
FIGURE 56 ASIA-PACIFIC HEART VALVE DEVICES MARKET: SNAPSHOT (2022)
FIGURE 57 ASIA-PACIFIC HEART VALVE DEVICES MARKET: BY COUNTRY (2022)
FIGURE 58 ASIA-PACIFIC HEART VALVE DEVICES MARKET: BY COUNTRY (2023 & 2030)
FIGURE 59 ASIA-PACIFIC HEART VALVE DEVICES MARKET: BY COUNTRY (2022 & 2030)
FIGURE 60 ASIA-PACIFIC HEART VALVE DEVICES MARKET: BY FUNCTIONALITY (2023-2030)
FIGURE 61 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET: SNAPSHOT (2022)
FIGURE 62 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET: BY COUNTRY (2022)
FIGURE 63 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET: BY COUNTRY (2023 & 2030)
FIGURE 64 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET: BY COUNTRY (2022 & 2030)
FIGURE 65 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET: BY PRODUCT TYPE (2023-2030)
FIGURE 66 GLOBAL HEART VALVE DEVICES MARKET: COMPANY SHARE 2021 (%)
FIGURE 67 NORTH AMERICA HEART VALVE DEVICES MARKET: COMPANY SHARE 2021 (%)
FIGURE 68 EUROPE HEART VALVE DEVICES MARKET: COMPANY SHARE 2021 (%)
FIGURE 69 ASIA-PACIFIC HEART VALVE DEVICES MARKET: COMPANY SHARE 2021 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.